Tetanus, Diphtheria, and Acellular Pertussis Vaccine: A Position Statement of the Society for Adolescent Medicine

Journal of Adolescent Health

Volumn 45, Issue 3, 2009, Pages 316-317

  Middleman, Amy B ^a   Bruner, Ann ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Mountain Manor Treatment Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ARTICLE; HUMAN; PERTUSSIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROPHYLAXIS; VACCINATION;

EID: 68749116408     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2009.06.019     Document Type: Note

References (5)

1. Cherry J., Xing D., Newland P., Patel K., et al. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Clin Infect Dis 38 (2004) 502-507
2. CDC. Pertussis surveillance report. MMWR Morb Mortal Wkly Rep 54 (2005) 770
3. CDC. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tentanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. MMWR Morb Mortal Wkly Rep 55 (2006) 1-34
4. CDC. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep 55 (2006) 1-33
5. CDC. Summary of ACIP recommendations for prevention of pertussis, tetanus and diphtheria among pregnant and postpartum women and their infants. MMWR Morb Mortal Wkly Rep 57 (2008) 48-49